DBV Technologies (DBVT) Interest Coverage Ratio (2014 - 2019)
DBV Technologies (DBVT) reported Interest Coverage Ratio of 1043.34 for Q3 2019, down 282.71% year-over-year from 571.03 in Q3 2018, and down 84.22% on a QoQ basis from 566.36 in Q4 2018.
DBV Technologies (DBVT) has 5 years of Interest Coverage Ratio data on file, last reported at 1043.34 in Q3 2019.
- Quarterly Interest Coverage Ratio fell 282.71% year-over-year to 1043.34 in Q3 2019, while the trailing twelve-month figure through Jun 2020 was 2192.63 (changed N/A YoY) and the FY2018 annual result came in at 473.51, up 985.93% from the prior year.
- Interest Coverage Ratio slipped to 1043.34 in Q3 2019 per DBVT's latest filing, from 566.36 in the prior quarter.
- Across five years, Interest Coverage Ratio topped out at 1299.37 in Q2 2016 and bottomed at 1043.34 in Q3 2019.
- The 4-year median for Interest Coverage Ratio is 177.58 (2015), against an average of 87.66.
- The widest annual swing landed in 2016, when Interest Coverage Ratio soared 631.7%; it then plunged 282.71% in 2019.
- Tracing DBVT's Interest Coverage Ratio over 4 years: stood at 177.58 in 2015, then jumped by 631.7% to 1299.37 in 2016, then slumped by 143.59% to 566.36 in 2018, then plunged by 84.22% to 1043.34 in 2019.
- Per Business Quant, the three latest DBVT Interest Coverage Ratio figures stand at 1043.34 (Q3 2019), 566.36 (Q4 2018), and 571.03 (Q3 2018).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | -129.79 |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 3.58 |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | -258.33 |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | - |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | 11.50 |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 49.84 |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 3.88 |
| 10 | DBV Technologies | 8.00 Bn | 7.77 Bn | -3.90 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2019 | -1,043.34 |
| Dec 31, 2018 | -566.36 |
| Sep 30, 2018 | 571.03 |
| Jun 30, 2016 | 1,299.37 |
| Jun 30, 2015 | 177.58 |
| Jun 30, 2014 | 469.14 |